This webinar will explain the final version of USP Chapter <1224> and FDA guidance for conducting and documenting method transfer between laboratories and sites, and provide tools for effective implementation.
Why Should You Attend:
When validated methods are transferred between laboratories and sites, their validated state should be maintained to ensure the same reliable results in the receiving laboratory. So far there has not been an official guidance on what exactly is expected to maintain 'the validated state'. This has changed since the USP has published the final version of the general chapter <1224>. Also the FDA has released an official guidance on how to conduct and document method transfer and FDA has been starting to enforce the new USP chapter. Now it is a good time to learn how to conduct and document method transfer.
This webinar will give a good understanding of USP and FDA requirements for transfer of analytical methods and provide recommendations and tools for effective implementation.
For easy implementation, attendees will receive
Areas covered in this webinar:
Who Will Benefit:
Duration: 75 Minutes
Physical CD-USB of recorded session will be despatched after 72 hrs on completion of payment
Dr. Ludwig Huber, Ph.D., is the director of Labcompliance and editor of www.labcompliance.com, the global online resource for validation and compliance. Dr. Huber is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems". He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world. This included seminars, workshops and presentations for the US FDA, China SFDA, Korea MFDS, Singapore HSA, ISPE, Japan PDA, PIC/S and several other national health care agencies.